Press coverage about K2M Group (NASDAQ:KTWO) has been trending positive recently, according to Accern. The research firm identifies negative and positive press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. K2M Group earned a media sentiment score of 0.25 on Accern’s scale. Accern also assigned news articles about the medical device company an impact score of 47.4529430238645 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
Here are some of the news articles that may have effected Accern Sentiment Analysis’s analysis:
A number of research firms recently weighed in on KTWO. BidaskClub raised K2M Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 10th. Oppenheimer set a $24.00 price objective on K2M Group and gave the company a “buy” rating in a research report on Thursday, March 1st. Barclays reaffirmed a “buy” rating and set a $25.00 price objective on shares of K2M Group in a research report on Tuesday, January 9th. Zacks Investment Research upgraded K2M Group from a “sell” rating to a “hold” rating in a research note on Thursday, January 25th. Finally, Needham & Company LLC increased their target price on K2M Group from $20.00 to $23.00 and gave the company a “buy” rating in a research note on Tuesday, January 9th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and nine have assigned a buy rating to the stock. K2M Group presently has an average rating of “Buy” and a consensus price target of $24.50.
Shares of KTWO opened at $19.37 on Friday. The company has a current ratio of 2.84, a quick ratio of 1.52 and a debt-to-equity ratio of 0.30. K2M Group has a 12 month low of $16.44 and a 12 month high of $25.99. The firm has a market cap of $840.43, a price-to-earnings ratio of -22.26 and a beta of 1.47.
K2M Group (NASDAQ:KTWO) last issued its earnings results on Wednesday, February 28th. The medical device company reported ($0.20) EPS for the quarter, missing the consensus estimate of ($0.19) by ($0.01). K2M Group had a negative net margin of 14.40% and a negative return on equity of 14.85%. The business had revenue of $67.80 million for the quarter, compared to analysts’ expectations of $67.36 million. During the same quarter in the prior year, the business posted ($0.30) earnings per share. The business’s revenue for the quarter was up 9.7% on a year-over-year basis. equities research analysts expect that K2M Group will post -0.72 earnings per share for the current year.
TRADEMARK VIOLATION WARNING: This story was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this story can be accessed at https://www.dispatchtribunal.com/2018/04/22/k2m-group-ktwo-receives-daily-media-sentiment-score-of-0-25.html.
K2M Group Company Profile
K2M Group Holdings, Inc, a medical device company, provides spine and minimally invasive solutions in the United States and internationally. The company offers implants, disposables, and instruments primarily to hospitals for use by spine surgeons to treat spinal pathologies, such as deformity, trauma, and tumor.
Receive News & Ratings for K2M Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group and related companies with MarketBeat.com's FREE daily email newsletter.